FIXX SHAREHOLDER ALERT: Jakubowitz Law Reminds Homology Shareholders of a Lead Plaintiff Deadline of May 24, 2022PRNewsWire • 05/20/22
FIXX LAWSUIT ALERT: Levi & Korsinsky Notifies Homology Medicines, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 05/19/22
TUESDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/19/22
Homology Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 24, 2022 to Discuss Your Rights - FIXXNewsfile Corp • 05/19/22
ROSEN, Top Ranked Investor Counsel, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 05/18/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys Before May 24th Deadline in Securities Class ActionNewsfile Corp • 05/18/22
Homology Medicines Presents Details of Optimized HMI-103 Nuclease-Free Gene Editing Candidate Featuring Integrated Liver-Specific Promoter to Maximize Long-Term ExpressionGlobeNewsWire • 05/18/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 24, 2022 - (NASDAQ: FIXX)PRNewsWire • 05/18/22
Homology Medicines (FIXX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/16/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys, May 24th Application Deadline Approaching in Securities Class ActionNewsfile Corp • 05/16/22
Homology Medicines Reports First Quarter 2022 Financial Results and Recent HighlightsGlobeNewsWire • 05/16/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXXPRNewsWire • 05/15/22
FIXX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Homology Medicines, IncNewsfile Corp • 05/13/22
Investor Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/11/22
ROSEN, A TOP RANKED LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 05/10/22
Investor Action Alert: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/09/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors With Losses to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXXPRNewsWire • 05/07/22
FIXX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity to Lead CasePRNewsWire • 05/06/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys, Application Deadline Approaching in Securities Class ActionNewsfile Corp • 05/06/22
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/06/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Class ActionNewsfile Corp • 05/04/22
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/04/22
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXXPRNewsWire • 05/03/22
Homology Medicines Announces Upcoming Presentation on Optimized In Vivo Gene Editing Candidate HMI-103 with First Details of Unique Mechanism of Action at ASGCT Annual MeetingGlobeNewsWire • 05/02/22
Shareholder Action Alert: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/02/22
